Paper - WANFANG MED ONLINE

You Position: Home > Paper

Recent advance in carbohydrate-based cancer vaccines

( views:37, downloads:0 )

Author:: No author available

Journal Title:: Acta Pharmaceutica Sinica

Issue:: 3

DOI:: No doi available

Key Word:: 肿瘤糖疫苗;免疫耐受;糖缀合物;代谢糖工程;交叉反应;抗体

Abstract：肿瘤细胞表面异常表达的糖抗原为肿瘤糖疫苗的研究提供了合适的靶标,然而由于这些糖抗原的免疫原性较差,这又给糖疫苗的发展带来了很大的困难.本文概述了近年来科学工作者在提高肿瘤糖疫苗的免疫原性方面所做的努力:半合成的肿瘤糖疫苗将糖抗原与蛋白共价连接,已经有很多疫苗进入了临床试验;随后发展的全合成的肿瘤糖疫苗将糖抗原、T细胞表位和内源性佐剂共价连接,使疫苗的结构和组成更加确定;基于细胞代谢糖工程的肿瘤糖疫苗将非天然的糖疫苗与细胞表面代谢糖工程相结合,得到了强烈的免疫应答；某些基于天然糖抗原结构修饰的疫苗产生的抗体也可以与天然糖抗原发生交叉反应,这为肿瘤糖疫苗的发展提供了新的方向.

Reference

[1]T, Kjeldsen,H, Clausen,S, Hirohashi,etc.Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.[J].1988,48.
[2]G, Ragupathi,M, Meyers,S, Adluri,etc.Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.[J].2000,85.
[3]Holmberg LA,Sandmaier BM.Vaccination with Theratope (STn-KLH) as treatment for breast cancer.[J].2004,3(6).
[4]Mersch, C,Wagner, S,Hoffmann-Roder, A.Synthesis of Fluorinated Analogues of Tumor-Associated Carbohydrate and Glycopeptide Antigens[J].2009,2009(13).
[5]Govind Ragupathi,Fusataka Koide,Natarajan Sathyan,etc.A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers[J].2003,52(10).
[6]Ragupathi G,Cappello S,Yi SS,etc.Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines[J].2002,20(7/8).
[7]M, Victorzon,S, Nordling,O, Nilsson,etc.Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer.[J].1996,65.
[8]Borrelli S,Gilbert M,Pon RA,etc.Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells.[J].2004,279(24).
[9]F, Helling,A, Shang,M, Calves,etc.GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.[J].1994,54.
[10]Leivonen M,Haglund C,Nordling S,etc.STn and prognosis in breast cancer.[J].2001,61(4).
[11]Clifford V.Harding,Nancy Nagy,Zhongwu Guo,etc.Efficient Metabolic Engineering of GM3 on Tumor Cells by N-Phenylacetyl-D-mannosamine[J].2006,45(11).
[12]Alexandra Hobel,Horst Kunz,Edgar Schmitt,etc.A Fully Synthetic Vaccine Consisting of a Tumor-Associated Glycopeptide Antigen and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response[J].2005,44(46).
[13]David R.Bundle,Jamie R.Rich,Sandra Jacques,etc.Thiooligosaccharide Conjugate Vaccines Evoke Antibodies Specific for Native Antigens[J].2005,44(47).
[14]S, Hakomori,Y, Zhang.Glycosphingolipid antigens and cancer therapy.[J].1997,4(2).
[15]Paszkiewicz E,Wu XY,Lipinski T,etc.Synthesis and immunochemical characterization of S-linked glycoconjugate vaccines against Candida albicans[J].2008,14(21).
[16]H, Kobayashi,T, Terao,Y, Kawashima.Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.[J].1992,10.
[17]Constantinos Sakarellos,Dimitrios Krikorian,Chryssa Voitharou,etc.A Peptide Carrier with a Built-in Vaccine Adjuvant:Construction of Immunogenic Conjugates[J].2005,16(4).
[18]J L, Werther,M, Tatematsu,R, Klein,etc.Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study.[J].1996,69.
[19]Buskas, T,Thompson, P,Boons, GJ.Immunotherapy for cancer: synthetic carbohydrate-based vaccines[J].2009,2009(36).
[20]V, Kudryashov,P W, Glunz,L J, Williams,etc.Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in mice.[J].2001,98.
[21]Qianli Wang,Jian Wu,Sandamali Amarasingha Ekanayaka.Synthetic and Immunological Studies of 5'-N-Phenylacetyl sTn to Develop Carbohydrate-Based Cancer Vaccines and to Explore the Impacts of Linkage between Carbohydrate Antigens and Carrier Proteins[J].2008,19(10).
[22]Lee M, Krug,Govind, Ragupathi,Kenneth K, Ng,etc.Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.[J].2004,10.
[23]Kennedy R,Celis E.Multiple roles for CD4+ T cells in anti-tumor immune responses.[J].2008,222(0).
[24]Ouerfelli O,Warren JD,Danishefsky SJ,etc.Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.[J].2005,4(5).
[25]Gargi Dasgupta,Lbachir BenMohamed,Olivier Renaudet.Towards a Self-Adjuvanting Multivalent B and T cell Epitope Containing Synthetic Glycolipopeptide Cancer Vaccine[J].2008,3(5).
[26]Nikola Gaidzik,Anton Kaiser,Danuta Kowalczyk.Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues[J].2011,50(42).
[27]Jian Wu,Zhongwu Guo.Improving the Antigenicity of sTn Antigen by Modification of Its Sialic Acid Residue for Development of Glycoconjugate Cancer Vaccines[J].2006,17(6).
[28]Ulevitch RJ,Hoebe K,Du X,etc.How we detect microbes and respond to them: the Toll-like receptors and their transducers.[J].2003,74(4).
[29]Zhongwu Guo,Qianli Wang.Recent development in carbohydrate-based cancer vaccines[J].2009,13(5).
[30]Wan Q,Ouerfelli O,Spassova MK,etc.Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: A synthetic route to anticancer vaccine candidates[J].2006,128(8).
[31]Grace E, Kim,Han-Ik, Bae,Hee-Ug, Park,etc.Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.[J].2002,123(4).
[32]Joerg Metzger,Guenther Jung,Wolfgang G. Bessler,etc.Lipopeptides containing 2-(palmitoylamino)-6,7-bis(palmitoyloxy)heptanoic acid: synthesis, stereospecific stimulation of B-lymphocytes and macrophages and adjuvanticity in vivo and in vitro[J].1991,34(7).
[33]霍常鑫,叶新山.肿瘤相关糖抗原STn硫苷类似物的合成[J].2009,(3).
[34]Richard Lo-Man,Sophie Vichier-Guerre,Edith Deriaud,etc.Anti-Tumor Immunity Provided by a Synthetic Multiple Antigenic Glycopeptide Displaying a Tri-Tn Glycotope[J].2001,166(4).
[35]S H, Itzkowitz,M, Yuan,C K, Montgomery,etc.Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer.[J].1989,49.
[36]Rich JR,Wakarchuk WW,Bundle DR.Chemical and chemoenzymatic synthesis of S-Linked ganglioside analogues and their protein conjugates for use as immunogens[J].2006,12(3).
[37]S, Zhang,L A, Walberg,S, Ogata,etc.Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.[J].1995,55.
[38]Seeberger, Peter H.,Hecht, Marie-Lyn,Adibekian, Alexander,etc.Recent advances in carbohydrate-based vaccines[J].2009,13(3).
[39]M, Fukuda.Possible roles of tumor-associated carbohydrate antigens.[J].1996,56.
[40]Nicole Bureaud,Gaelle-Anne Cremer,Veronique Piller.Synthesis and Biological Evaluation of a Multiantigenic Tn/TF-Containing Glycopeptide Mimic of the Tumor-Related MUC1 Glycoprotein[J].2006,1(9).
[41]R, Lo-Man,S, Bay,S, Vichier-Guerre,etc.A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.[J].1999,59.
[42]Peter H. Seeberger.Automated oligosaccharide synthesis[J].2008,37(1).
[43]P B, Chapman,D M, Morrissey,K S, Panageas,etc.Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.[J].2000,6.
[44]Brock R,Jung G,Spohn R,etc.Synthetic lipopeptide adjuvants and Toll-like receptor 2 - structure-activity relationships[J].2004,22(19).
[45]R A, Pon,M, Lussier,Q L, Yang,etc.N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.[J].1997,185.
[46]Venerando B,Preti A,Monti E,etc.The plasma membrane-associated sialidase MmNEU3 modifies the ganglioside pattern of adjacent cells supporting its involvement in cell-to-cell interactions.[J].2004,279(17).
[47]Richard, Lo-Man,Sophie, Vichier-Guerre,Ronald, Perraut,etc.A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates.[J].2004,64.
[48]Hoffmann-R?der, A.,Oberbillig, T.,Johannes, M..Synthesis of fluorinated Thomsen-Friedenreich antigens: Direct deoxyfluorination of αgalNAc-threonine tert-butyl esters[J].2011,9(15).
[49]Frank Reichel,Peter R. Ashton,Geert-Jan Boons.Synthetic carbohydrate-based vaccines: synthesis of an L-glycero-D-manno-heptose antigen-T-epitope-lipopeptide conjugate[J].1997,(21).
[50]Wan, Q,Spassova, MK,Damani, P,etc.From Synthesis to Biologics: Preclinical Data on a Chemistry Derived Anticancer Vaccine[J].2009,131(26).
[51]SYLVIE BAY,RICHARD LO-MAN,EDUARDO OSINAGA,etc.Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. A possible approach to a synthetic carbohydrate vaccine[J].1997,49(6).
[52]Goldman Bruce,DeFrancesco Laura.The cancer vaccine roller coaster[J].2009,27(2).
[53]Sames D,Musselli C,Schwarz JB,etc.Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.[J].2003,21(23).
[54]Danishefsky SJ,Keding SJ.Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors[J].2004,101(33).
[55]Lilleby K,Sandmaier BM,MacLean GD,etc.Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine.[J].2000,25(12).
[56]Nagy N,Pan YB,Harding C,etc.Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines[J].2005,48(3).
[57]Lbachir BenMohamed,Susan Yoon,Olivier Renaudet,etc.Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes.[J].2009,58(2).
[58]Haisheng Wang,Lijun Huang,Xuefei Huang,etc.Iterative One-Pot Synthesis of Oligosaccharides[J].2004,43(39).
[59]Sarah Wagner,Anton Kaiser,Anja Hoffmann-Roder.Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue[J].2010,49(45).
[60]Reno D. Astronomo,Dennis R. Burton.Carbohydrate vaccines: developing sweet solutions to sticky situations?[J].2010,9(4).
[61]Zhang J,Wang Q,Guo Z.Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell.[J].2007,15(24).
[62]Therese Buskas,Sampat Ingale,Geert-Jan Boons.Towards a Fully Synthetic Carbohydrate-Based Anticancer Vaccine:Synthesis and Immunological Evaluation of a Lipidated Glycopeptide Containing the Tumor-Associated Tn Antigen[J].2005,44(37).
[63]Jamie R. Rich,David R. Bundle.S-Linked Ganglioside Analogues for Use in Conjugate Vaccines[J].2004,6(6).
[64]Ingale, S,Buskas, T,Boons, GJ,etc.Increasing the Antigenicity of Synthetic Tumor-Associated Carbohydrate Antigens by Targeting Toll-Like Receptors[J].2009,10(3).
[65]Mersch, C.,Hoffmann-R?der, A.,Wagner, S..Fluorinated glycosyl amino acids for mucin-like glycopeptide antigen analogues[J].2010,16(24).
[66]P, Livingston.The unfulfilled promise of melanoma vaccines.[J].2001,7(7).
[67]Tatsushi Toyokuni,Barbara Dean,Shaopei Cai,etc.Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins[J].1994,116(1).
[68]S H, Itzkowitz,E J, Bloom,W A, Kokal,etc.Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients.[J].1990,66(9).
[69]Zheng, Xiu-Jing,Zhang, Ye,Ye, Xin-Shan,etc.Enhancement of the Immunogenicity of Synthetic Carbohydrate Vaccines by Chemical Modifications of STn Antigen[J].2011,6(3).
[70]Bresalier R S,Niv Y,Byrd J C,etc.Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.[J].1991.
[71]Ingale S,Buskas T,Boons GJ.Synthesis of glyco(lipo) peptides by liposome-mediated native chemical Ligation[J].2006,8(25).
[72]Margreet A Wolfert,Sampat Ingale,Therese Buskas,etc.Robust immune responses elicited by a fully synthetic three-component vaccine[J].2007,3(10).
[73]Zhongwu Guo,Qianli Wang.Synthetic and Immunological Studies of sTn Derivatives Carrying Substituted Phenylacetylsialic Acids as Cancer Vaccine Candidate[J].2011,2(5).
[74]Hoffmann-R?der, A.,Johannes, M..Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen[J].2011,47(35).
[75]Geert-Jan Boons,Yanhong Li,Therese Buskas.The Immunogenicity of the Tumor-Associated Antigen Lewis~y May Be Suppressed by a Bifunctional Cross-Linker Required for Coupling to a Carrier Protein[J].2004,10(14).
[76]Nikola Gaidzik,Ulrika Westerlind,Alexandra Hobel.Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopep- tide Antigens and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response[J].2008,47(39).